Who Paid My Doc
Vivjoa
Drug Infections and Infectious Diseases
NDC 74695-823-18
General payments
$70,535
Research payments
$9,000
Through program year 2025, $70,535 in general payments and $9,000 in research payments were reported against Vivjoa (Infections and Infectious Diseases).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
5 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $21,228 | 14 |
| 2025 | Research | $9,000 | 1 |
| 2024 | General | $7,418 | 16 |
| 2023 | General | $29,630 | 1,014 |
| 2022 | General | $12,259 | 333 |
Breakdown
Each share is of general payments naming this product in 2025.
Each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
Each share is of general payments naming this product in 2025 where a state was reported.
Records
1,377 general · 1 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.